IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

MANCUSO, MARIA ELISA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.404
NA - Nord America 1.583
AS - Asia 774
SA - Sud America 26
Continente sconosciuto - Info sul continente non disponibili 10
AF - Africa 8
OC - Oceania 2
Totale 4.807
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.548
GB - Regno Unito 934
DE - Germania 462
CN - Cina 378
SE - Svezia 359
IT - Italia 214
SG - Singapore 155
UA - Ucraina 76
IN - India 75
RU - Federazione Russa 72
IE - Irlanda 68
TR - Turchia 53
FI - Finlandia 51
KR - Corea 47
EU - Europa 42
FR - Francia 41
NL - Olanda 33
DK - Danimarca 31
CA - Canada 27
BE - Belgio 23
CO - Colombia 19
HK - Hong Kong 15
ID - Indonesia 14
JP - Giappone 12
IR - Iran 10
GR - Grecia 8
MX - Messico 8
CH - Svizzera 6
RO - Romania 6
BR - Brasile 5
MY - Malesia 5
NO - Norvegia 5
AT - Austria 4
ZA - Sudafrica 4
EG - Egitto 3
ES - Italia 3
AU - Australia 2
CL - Cile 2
CZ - Repubblica Ceca 2
PL - Polonia 2
PT - Portogallo 2
QA - Qatar 2
TW - Taiwan 2
BY - Bielorussia 1
CY - Cipro 1
HU - Ungheria 1
IL - Israele 1
MA - Marocco 1
OM - Oman 1
PK - Pakistan 1
TH - Thailandia 1
UZ - Uzbekistan 1
Totale 4.839
Salva come PNG Salva come JPEG
Città #
Southend 837
Hanover 240
Chandler 179
Houston 143
Seattle 105
Singapore 102
Milan 99
Princeton 89
Ann Arbor 82
Wilmington 78
Fairfield 74
Frankfurt am Main 74
Ashburn 72
Beijing 69
Dublin 68
Woodbridge 54
Dearborn 46
Jacksonville 45
Nanjing 35
Des Moines 31
Redmond 31
Bengaluru 29
Boardman 28
Mountain View 28
Redwood City 28
Somerville 26
Cambridge 25
Jinan 23
Helsinki 22
Serra 21
Shenyang 21
Andover 20
Margão 20
Bogotá 19
Sakarya 19
Hangzhou 17
Berlin 16
Santa Clara 16
Shanghai 16
Brussels 15
Nanchang 15
Phoenix 15
Toronto 15
Hebei 14
Tianjin 14
Changsha 12
Fuzhou 12
Guangzhou 12
New York 12
Roxbury 12
Saint Petersburg 12
Munich 11
Ottawa 10
Hong Kong 8
London 8
Silver Spring 8
Taizhou 8
Athens 7
Jakarta 7
Duncan 6
Eitensheim 6
Ningbo 6
San Diego 6
Wuhan 6
Amsterdam 5
Antwerpen 5
Bitonto 5
Fremont 5
Istanbul 5
Kunming 5
Pisa 5
Atlanta 4
Chennai 4
Grafing 4
Haikou 4
Hamburg 4
Iowa City 4
Medford 4
Washington 4
Bangalore 3
Columbus 3
Jiaxing 3
Kenilworth 3
Mexico 3
Pars 3
Rotterdam 3
São Paulo 3
Tehran 3
Verona 3
Xian 3
Zhengzhou 3
Auburn Hills 2
Aurora 2
Bergamo 2
Bolzano 2
Boston 2
Bristol 2
Bühl 2
Carol Stream 2
Central District 2
Totale 3.325
Salva come PNG Salva come JPEG
Nome #
A Randomized Trial of Factor VIII and Neutralizing Antibodies in Hemophilia A 533
Whole-exome sequencing to identify genetic risk variants underlying inhibitor development in severe hemophilia A patients 389
Cognitive and psychological profiles in treatment compliance: a study in an elderly population with hemophilia 244
Genome-wide haplotype association study identifies the FRMD4A gene as a risk locus for Alzheimer's disease 162
Circulating endothelial cells (CECs) and progenitors (CEPs) in severe haemophiliacs with different clinical phenotype 147
Absence of association between erythropoietin gene variation and ALS in sporadic Italian patients. 144
A recurrent F8 mutation (c.6046C>T) causing hemophilia A in 8% of northern Italian patients : evidence for a founder effect 141
Association study between XRCC1 gene polymorphisms and sporadic amyotrophic lateral sclerosis 135
Mutational Repertoire in the SIPPET Cohort and Prediction of FVIII Inhibitor Risk 132
Immune tolerance induction with recombinant factor VIII in hemophilia A patients with high responding inhibitors 131
The Influence of F8 Mutation and Thrombophilic Genetic Markers on Bleeding Phenotype of Patients Affected with Severe Hemophilia A in the SIPPET Cohort 130
The natural history of hepatitis C virus infection in Italian patients with von Willebrand's disease : A cohort study 128
Rescue FVIII replacement to secure haemostasis in a patient with haemophilia A and inhibitors on emicizumab prophylaxis undergoing hip replacement 128
Solvent/detergent plasma for prevention of bleeding in recessively inherited coagulation disorders : dosing, pharmacokinetics and clinical efficacy 124
High efficacy of combined therapy with pegylated interferon plus ribavirin in patients with hemophilia and chronic hepatitis C 120
Sequential combined bypassing therapy : a rescue option in refractory bleeds – the Italian experience 120
Involvement of the IgE-basophil system and mild complement activation in haemophilia B with anti-factor IX neutralizing antibodies and anaphylaxis 119
Progranulin genotyping in 237 sporadic amyothropic lateral sclerosis patients 118
Environmental risk factors for inhibitor development in children with haemophilia A : a case-control study 115
Severe hemophilia with mild bleeding phenotype : molecular characterization and global coagulation profile 115
Factors influencing the long-term outcome of primary total knee replacement in haemophiliacs : a review of 116 procedures at a single institution 113
Lupus anticoagulants and their relationship with the inhibitors against coagulation factor VIII : considerations on the differentiation between the 2 circulating anticoagulants 113
Feasibility of prophylaxis and immune tolerance induction regimens in haemophilic children using fully implantable central venous catheters 112
A prospective randomized trial of high and standard dosages of recombinant factor VIIa for treatment of hemarthroses in hemophiliacs with inhibitors 109
Low-rate of complications after a long-term use of ateriovenous fistula (AVF) in hemophilic children 108
Increased thrombin generation in severe hemophiliacs with mild clinical phenotype 107
Interferon lambda 3 rs12979860 polymorphism in patients with haemophilia and HCV infection : a predictor of spontaneous viral clearance and sustained virological response 106
Fatigue and exercise intolerance in mitochondrial diseases. Literature revision and experience of the Italian Network of mitochondrial diseases 103
Platelets from glioblastoma patients promote angiogenesis of tumor endothelial cells and exhibit increased VEGF content and release 96
Sequential combined bypassing therapy is safe and effective in the treatment of unresponsive bleeding in adults and children with haemophilia and inhibitors 94
Ageing successfully with haemophilia : A multidisciplinary programme 90
Applying a deliberation model to the analysis of consultations in haemophilia: Implications for doctor-patient communication 87
Integrated postural analysis in children with haemophilia 81
Type and intensity of FVIII exposure on inhibitor development in PUPs with haemophilia A : a patient-level meta-analysis 78
Sequential combined bypassing therapy is safe and effective in the treatment of unresponsive bleeding in adults and children with haemophilia and inhibitors 70
X Chromosome inactivation: a modifier of factor VIII and IX plasma levels and bleeding phenotype in Haemophilia carriers 63
Handwriting Analysis in Children and Adolescents with Hemophilia : A Pilot Study 60
Polypharmacy in older adults with severe haemophilia 50
Evaluation of an automated chromogenic assay for Factor VIII clotting activity measurement in patients affected by haemophilia A 50
Acquired inhibitors of clotting factors: AICE recommendations for diagnosis and management 44
Emicizumab prophylaxis in infants with hemophilia A (HAVEN 7): primary analysis of a phase 3b open-label trial 12
null 5
Totale 5.126
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.603
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.603
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020647 0 0 0 55 76 107 70 39 139 106 32 23
2020/2021568 39 52 53 28 61 47 45 31 56 43 85 28
2021/2022708 63 19 20 67 52 66 68 48 63 82 56 104
2022/2023712 112 102 56 67 76 131 6 60 70 3 19 10
2023/2024350 11 34 15 33 88 21 18 11 9 22 42 46
2024/2025206 51 105 26 24 0 0 0 0 0 0 0 0
Totale 5.126